Vaxart, Inc. (VXRT): Net Income
$16.33M
Year ended 2025-12-31
$38.59M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $16.33M | n/m | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | -$66.95M | n/m | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | -$82.47M | n/m | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | -$107.76M | n/m | 2024-03-14, From 2022-01-01 |
| 2021-12-31 | -$70.47M | n/m | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | -$32.22M | n/m | 2022-02-24, From 2020-01-01 |
| 2019-12-31 | -$18.64M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$18.01M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$9.58M | n/a | 2019-02-06, From 2017-01-01 |
| No annual figure between 2016-06-30 and 2017-12-31. | |||
| 2016-06-30 | -$25.40M | n/m | 2017-09-01, From 2015-07-01 |
| 2015-06-30 | -$19.10M | n/m | 2016-09-13, From 2014-07-01 |
| 2014-06-30 | -$11.00M | n/m | 2016-09-13, From 2013-07-01 |
| 2013-06-30 | -$8.90M | n/m | 2015-09-11, From 2012-07-01 |
| 2012-06-30 | -$19.20M | n/m | 2014-09-30, From 2011-07-01 |
| 2011-06-30 | -$25.40M | n/a | 2013-09-27, From 2010-07-01 |
| No annual figure between 2009-12-26 and 2011-06-30. | |||
| 2009-12-26 | -$18.73M | n/a | 2012-03-14, From 2008-12-28 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Vaxart, Inc. (VXRT) | 2025-12-31 | $16.33M | n/m |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | -$390.98M | n/m |
| Vericel Corp (VCEL) | 2025-12-31 | $16.52M | +59.4% |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | -$59.50M | n/m |
| Adaptimmune Therapeutics PLC (ADAPY) | 2024-12-31 | -$70.81M | n/m |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | -$193.88M | n/m |
| Ginkgo Bioworks Holdings, Inc. (DNA) | 2025-12-31 | -$312.76M | n/m |
| Twist Bioscience Corp (TWST) | 2025-09-30 | -$77.67M | n/m |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $204.83M | +129.7% |
Compare VXRT, IOVA, VCEL, ADPT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗